Translating Aging

Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis)


Listen Later

Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits. In this episode, Chris and Hans discuss Immunis' approach to targeting the aging immune system as a key driver of age-related disease. They explore the potential of immune secretome factors to restore youthful immune function, the promising results from Immunis' preclinical and early clinical studies, and the future of immune-modulating therapeutics to extend healthspan.

THE FINER DETAILS

  • The critical role of the immune system in the aging process and age-related disease
  • Immunis' focus on immune precursor cell secretome factors to restore youthful immune function
  • Preclinical studies demonstrating the effects of Immunis' secretome product on muscle growth, metabolism, and inflammation in aged mice
  • Early results from Immunis' Phase 1/2a clinical trial in older adults with muscle atrophy and knee osteoarthritis
  • The potential for immune secretome therapeutics to treat a wide range of age-related conditions and enhance healthspan
  • The importance of developing affordable and accessible therapies to maximize impact

QUOTES

  • "Every manifestation of aging is immunologically mediated. It's phenomenal. When one ages, your immune system in 100% of humans gets angry, so becomes highly pro-inflammatory."
  • "Our drug is not a stem cell. It's not an immune cell. It is the secretion set, that same secretion set that you and I have, and everyone on this earth has, that precipitously declines with age, and now we're able to restore it."
  • "We showed that IMMUNA fundamentally changes gene expression in order to promote the expression of genes for growth and regeneration. And then it inhibits the expression of genes that inhibit growth and regeneration."
  • "I believe that this [secretome therapeutic] is going to be taken prophylactically by most humans, every quarter or so, to keep their immune system young, keep their immune system in a prophylactically competent state."
  • "I want this thing to be available to everyone who wants it at an extremely low price, so that we can keep people alive, so that we can keep them disease free, so they can have productive years in their golden times, in their older age."

LINK TO PAPER

Stem cell secretome treatment improves whole-body metabolism, reduces adiposity, and promotes skeletal muscle function in aged mice

...more
View all episodesView all episodes
Download on the App Store

Translating AgingBy BioAge Labs

  • 5
  • 5
  • 5
  • 5
  • 5

5

11 ratings


More shows like Translating Aging

View all
The Knowledge Project by Shane Parrish

The Knowledge Project

2,680 Listeners

Making Sense with Sam Harris by Sam Harris

Making Sense with Sam Harris

26,351 Listeners

Conversations with Tyler by Mercatus Center at George Mason University

Conversations with Tyler

2,447 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,093 Listeners

FYI - For Your Innovation by ARK Invest

FYI - For Your Innovation

394 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

9,198 Listeners

Your Undivided Attention by The Center for Humane Technology, Tristan Harris, Daniel Barcay and Aza Raskin

Your Undivided Attention

1,603 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

9,956 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

499 Listeners

Hard Fork by The New York Times

Hard Fork

5,488 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,264 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

16,096 Listeners

Longevity by Design by Gil Blander PhD

Longevity by Design

184 Listeners

Moonshots with Peter Diamandis by PHD Ventures

Moonshots with Peter Diamandis

542 Listeners

The AI Daily Brief: Artificial Intelligence News and Analysis by Nathaniel Whittemore

The AI Daily Brief: Artificial Intelligence News and Analysis

594 Listeners